These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23114631)

  • 1. What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture?
    Aubry-Rozier B; Stoll D; Krieg MA; Lamy O; Hans D
    Clin Rheumatol; 2013 Feb; 32(2):219-23. PubMed ID: 23114631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Were you identified to be at high fracture risk by FRAX® before your osteoporotic fracture occurred?
    Chen XF; Li XL; Zhang H; Liu GJ
    Clin Rheumatol; 2014 May; 33(5):693-8. PubMed ID: 24577817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
    Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
    Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women.
    Lippuner K; Johansson H; Kanis JA; Rizzoli R
    Osteoporos Int; 2009 Jul; 20(7):1131-40. PubMed ID: 18974918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is It Possible to Increase the Clinical Effectiveness of the Fracture Risk Assessment Tool in Osteopenia Patients by Taking Into Account Bone Mineral Density Values?
    Park JS; Lee J; Park YS
    J Clin Densitom; 2016; 19(3):340-5. PubMed ID: 26822485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRAX score with and without bone mineral density: a comparison and factors affecting the discordance in osteoporosis treatment in Thais.
    Teeratakulpisarn N; Charoensri S; Theerakulpisut D; Pongchaiyakul C
    Arch Osteoporos; 2021 Feb; 16(1):44. PubMed ID: 33635451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
    Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
    Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
    J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAX assessment of osteoporotic fracture probability in Switzerland.
    Lippuner K; Johansson H; Kanis JA; Rizzoli R
    Osteoporos Int; 2010 Mar; 21(3):381-9. PubMed ID: 19517155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.
    Leslie WD; Majumdar SR; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    Osteoporos Int; 2012 Jan; 23(1):391-7. PubMed ID: 21365460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
    Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
    Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease.
    Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC
    Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probability of the 10-year Risk of Hip and Major Osteoporotic Fracture in Non-radiographic Axial Spondyloarthritis.
    Ferjani HL; Boudriga O; Nessib DB; Kaffel D; Maatallah K; Hamdi W
    Curr Rheumatol Rev; 2024; 20(1):82-87. PubMed ID: 37539931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilize polygenic risk score to enhance fracture risk estimation and improve the performance of FRAX in patients with osteoporosis.
    Chen JJ; Chen IC; Wei CY; Lin SY; Chen YM
    Arch Osteoporos; 2023 Dec; 18(1):147. PubMed ID: 38036866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative bone health assessment and optimization in spine surgery.
    Anderson PA; Kadri A; Hare KJ; Binkley N
    Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV.
    Vizcarra P; Gallego J; Vivancos MJ; Sifuentes WA; Llop M; Casado JL
    HIV Res Clin Pract; 2020; 21(2-3):63-71. PubMed ID: 32698706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
    Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
    Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.